News 2025
25.03.2025
Successful 2nd Edition of the “Bacterial Genome Sequencing Pan-European Network Conference” in Engelberg, Switzerland
A coalition of leading tuberculosis (TB) experts and medical societies is calling for an urgent expansion of the European Medicines Agency (EMA) label for pretomanid, a key drug in the fight against multidrug-resistant tuberculosis (MDR-TB) and rifampicin-resistant TB (RR-TB). This appeal aligns with the latest World Health Organization (WHO) guidelines and aims to improve patient access to more effective and tolerable treatment regimens.
18.03.2025
Tuberculosis trends in Europe: Rising drug-resistant cases demand urgent action
A team of researchers from the Research Center Borstel in Germany, Imperial College London in the UK, and the European Centre for Disease Prevention and Control (ECDC) in Stockholm, Sweden, has analyzed tuberculosis notification rates across the European Union/European Economic Area (EU/EEA) from 2019 to 2023.
14.03.2025
Open letter: Experts urge urgent expansion of Pretomanid label to improve tuberculosis treatment access in Europe
A coalition of leading tuberculosis (TB) experts and medical societies is calling for an urgent expansion of the European Medicines Agency (EMA) label for pretomanid, a key drug in the fight against multidrug-resistant tuberculosis (MDR-TB) and rifampicin-resistant TB (RR-TB). This appeal aligns with the latest World Health Organization (WHO) guidelines and aims to improve patient access to more effective and tolerable treatment regimens.
12.03.2025
Rising antibiotic resistance threatens tuberculosis control in Ukraine
A recent study by researchers from the National University V.N. Karazin in Kharkiv, the State University of Medicine and Pharmacy in Chisinau, Republic of Moldova, and the Borstel Research Centre, Leibniz Lung Centre, shows an alarming increase in fluoroquinolone resistance in patients with drug-resistant tuberculosis in eastern Ukraine.
